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ABSTRACT

A method is provided for preparing shells, concentric shells
or porous, homogenous gels from alkali borate glass par
ticles at low temperatures (i.e. room temperature or less than
above 100° C.). The alkali borate glass particles contain one
or more cations such as aluminum which react with an
aqueous solution containing an anion such as hydroxide to
form an aqueous insoluble material having a solubility limit
of less than about 0.01 wt. percent. TTie resulting shells or
gels may be used in many different applications such as a
filler in resins, as filters, precursors for nano-sized powders,
as thin surface films or catalyst support media. The resulting
shells or gels may also have a chemotherapeutic drug added
thereto, following which the resulting product is adminis
tered to a mammal and the insoluble material is dissolved
form the product in vivo through administration of chelating
agent.
38 Claims, 12 Drawing Sheets
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METHOD FOR PREPARING POROUS
SHELLS OR GELS FROM GLASS
PARTICLES

larly for processes which can be carried out at low tempera
tures (<100° C.) and which can produce hollow, porous
microspheres of many different chemical compositions.

BACKGROUND OF THE INVENTION
SUMMARY OF THE INVENTION
5
This invention relates to a method for preparing a shell or
Among the several objects of the invention may be noted
porous gel from glass particles and, more particularly, to
the provision of a method for preparing from glass particles
such a method in which glass particles are reacted, nona product composed of a shell filled with colloidal particles
uniformly corroded or partially dissolved to convert solid
glass particles into a product composed of shells, concentric 10 or gel, concentric shells, or a porous, homogenous gel; the
provision of such a method by which porous/hollow shells
shells or a porous, homogeneous gel which can be used in
may be produced at or near room temperature; the provision
various applications.
of a method of the type described which advantageously
Hollow glass microspheres have been produced in large
produces a porous product which may be filled with various
quantities since the 1930’s (C. D. Hendricks, “Glass
Spheres”, in Ceramics and Glasses, Vol. 4 Engineered 15 types of liquids and gases; the provision of such a method
which allows hollow/porous products of many different
Materials Handbook, 418-422, ASM International, USA
chemical compositions to be prepared; and the provision of
(1991); and Neusy U.S. Pat. No. 4,487,620). Traditionally
a method for administering a chemotherapeutic drug which
hollow glass microspheres have been processed by mixing
permits porous microspheres formed by glass particle/
glass forming raw materials (i.e. soda, lime and silica) with
an organic material such as urea. These materials are mixed 20 solution reactions to be dissolved with a chelating agent.
Other objects and features will be in part apparent and in part
into a slurry, which is subsequently dried into a cake and
pointed out hereinafter.
crushed into small (<200 /im) particles. The particles are
Briefly, the present invention in one aspect is directed to
then introduced into a high temperature flame where the
a method for preparing a shell or porous gel from glass
glass forming materials melt, and the gas released from
decomposition of the organic material forms hollow glass 25 particles which involves the steps of:
microspheres. Many refinements of this general technique
(a) forming particles of an alkali borate glass composition
have been used to make the majority of hollow microspheres
containing one or more cations which react with an
which are now commercially available. The main disadvan
aqueous solution containing an anion reactive with the
tage of this method is that flame temperatures exceeding
cation to form an aqueous insoluble material having a
1200° C. must be used to produce the hollow microspheres. 30
solubility limit of less than about 0.01 wt. percent;
The hollow microspheres made using this “burn out”
(b) immersing the glass composition particles in the
method are primarily used as fillers in light weight polymers,
aforementioned aqueous solution so that the particles
high temperature insulation and as fillers in paints (C. D.
react and form the insoluble material which is essen
Hendricks, supra; L. H. Smiley, “Hollow Microspheres:
tially the same size as the as-made particles with the
More Than Just Fillers, Mech. Eng. Feb. 27-30 (1986); and 35
alkali and borate dissolving from the glass particles;
R. H. Wehrenberg, “Shedding Pounds in Plastics: Micro
and
spheres are Moving”, Mech. Eng. Oct. 58-63 (1978)).
(c) allowing the chemical reaction to continue until the
Hollow glass microspheres can also be produced using
alkali and boron are substantially completely dissolved
sol-gel processing (R. L. Downs et al., “Hollow Glass
from the glass particles and the resulting product is
Microspheres by Sol-Gel Technology” in Sol-Gel Technol 40
composed of a shell filled with colloidal particles or
ogy for Thin Films, Fibers, Preforms, Electronics and Spe
gel, concentric shells or a porous, homogeneous gel,
cialty Shapes, Ed. L. Klein, 330-380, Noyes Publications,
the product being nonradioactive and not adapted for
NJ, (1988); L. C. Klein, “Sol-Gel Process” in Ceramics and
neutron irradiation.
Glasses, Vol. 4 Engineered Materials Handbook, 209-214,
In another aspect, the invention is directed to a method for
ASM International, USA(1991); and R. D. Shoup, “Sol-Gel 45 administering a chemotherapeutic drug which involves the
Processes”, in Ceramics and Glasses, Vol. 4 Engineered
three above-noted steps and the additional steps of adding a
Materials Handbook, 445-452, ASM International, USA
chemotherapeutic drug to the above-noted resulting product
(1991)). A sol is first prepared by mixing metal alkoxides,
and administering the then resulting product to a mammal,
such as tetraethylorthosilicate (TEOS), with water and etha
and thereafter dissolving the insoluble material from this
nol. This sol is then heated and acid catalyzed to form a 50 product in vivo through the administration of a chelating
silicate gel. The gel is dried and crushed into particles which
agent. Another additional step may involve heat treating the
are spheroidized in a high temperature (>1200° C.) flame.
above-noted resulting product so as to improve its mechani
While in the flame, the gel particles melt and decomposing
cal strength or to control its porosity/permeability for the
organic groups release gas to form hollow glass micro
purpose of controlling the rate at which a drug is released or
spheres. This technique is used to prepare hollow glass 55 the product may be filled with a drug.
microspheres with very high purity and uniform wall thick
nesses. The sol gel processing of hollow glass microspheres
BRIEF DESCRIPTION OF THE DRAWINGS
is very costly due to the high cost of the metal alkoxides used
FIG. 1 shows optical micrographs of pure Li20 3—B20 3
as raw materials. Sol gel processing also requires high
temperatures and multiple processing steps which must be 60 glass microspheres immersed in a phosphate buffered saline
(PBS) solution at 37° C. for 0, 5, 10, 15, 20 and 25 minutes
closely monitored. Thus, this technique is only used for very
with the microspheres progressively shrinking in size as they
specialized applications such as the formation of hollow
uniformly dissolve in the solution;
microspheres which are impregnated with deuterium and
tritium for use in laser fusion experiments (R. H.
FIG. 2 shows optical micrographs of three Dy20 3—
Wehrenberg, supra).
65 Li20 —B20 3 glass microspheres immersed in PBS solution
There is a continuing need for improved processes for
at 37° C. for 0, 15, 30, 45, 60 and 75 minutes. A spherical
preparing a shell or porous gel from glass particles, particu
core of the “as-made” glass is clearly visible after 15
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minutes and the core becomes progressively smaller until it
aqueous solution containing an anion such as hydroxide or
is no longer detectable after 75 minutes;
phosphate to form an aqueous insoluble material having a
solubility limit of less than about 0.01 wt. %. When the
FIG. 3 is a schematic model of the chemical reaction
alkali borate glass composition particles are immersed in an
occurring between a borate glass and a solution, such as
PBS, where an insoluble material is formed as a series of 5 aqueous solution, such as a body fluid for example, nonuniform reaction, corrosion or dissolution of the glass par
concentric shells;
ticles occurs and the reaction between the cation in the glass
FIG. 4 is a cross-sectional view of a Dy20 3—Li20 —
composition and the anion in the aqueous solution forms an
B20 3 glass microsphere which has been immersed in PBS
insoluble material which is essentially the same size and
solution for 24 hours at 37° C. and then impregnated with
polymethyl methacrylate. The white region is composed of 10 shape as the “as-made” particles, see FIG. 2.
FIG. 3 shows a schematic representation of the mecha
an amorphous, porous dysprosium phosphate gel;
nisms which occur during the non-uniform reaction of the
FIG. 5 is a high magnification SEM micrograph showing
alkali borate glass compositions. As shown, during the
the smooth, external surface of an “as-made” Dy20 3—
chemical reaction, the alkali and boron ions dissolve from
Li20 —B20 3 glass microsphere;
15 the glass particles or microspheres and go into solution. The
FIG. 6 is a high magnification SEM micrograph showing
insoluble cations in the glass (e.g. Ca2+, Dy3+) react with
the surface of a Dy20 3—Li20 —B20 3 glass microsphere
OH- and/or PO4- anions present in the aqueous solution
which was immersed in PBS solution for 24 hours at 37° C.;
(e.g. saline solution or body fluid) to form an insoluble
FIG. 7 is a backscatter SEM image of a cross-sectioned
oxide, hydroxide or phosphate gel on or around the micro
Dy20 3—Li20 —B20 3 microsphere which initially con 20 spheres or glass particles. In one aspect of the invention, this
tained 3 wt. % Dy20 3, and was fully reacted with PBS
insoluble gel initially forms at the original surface of the
solution at 37° C.;
“as-made” particles or microspheres. Thus, the gel remains
the same shape and size as the “as-made” particles or
FIG. 8 is a backscatter SEM image of a cross-sectioned
microspheres. As the non-uniform reaction progresses
Dy20 3—Li20 —B20 3 glass microsphere which initially
contained 10 wt. % Dy20 3 and was fully reacted with PBS 25 inward, toward the center of the microsphere, the dissolving
core can separate from the outer shell depending upon the
solution at 37° C.;
content of the reacting cation in the glass and the rate at
FIG. 9 is a backscatter SEM image of a cross-sectioned
which the glass reacts with the solution. As this core
Dy20 3—Li20 —B20 3 glass microsphere which initially
detachment occurs, another shell can begin to form around
contained 30 wt. % Dy20 3, and was fully reacted with PBS
30 the separated core as it continues to react non-uniformly.
solution at 37° C.;
These shell formation and disconnection or detachment
FIG. 10 shows optical micrographs of Dy20 3—Li20 —
steps continue to occur until the inner core of “as-made”
B20 3 glass microspheres and borosilicate glass particles
glass has completely reacted. The resulting reaction product
immersed in PBS solution at 37° C. (A, B and C). At 1 hr:42
minutes, 25 fil of 0.75M EDTA solution was added and 35 is generally composed of concentric shells of an amorphous,
or crystalline highly porous solid.
complete chelation (dissolution) of the spherical dysprosium
By varying the amount of insoluble cation present in the
phase was observed at 2 hr:05 minutes (E and F). The
glass composition used for the glass/aqueous solution
bottom micrographs D, E and F show the disappearance of
reaction, one can obtain resulting products having one of
the shells after the addition of EDTA, but the angular,
three different microstructures as shown in FIGS. 7-9. The
irregular borosilicate glass particles remain unaffected;
40
microstructures shown in FIGS. 7-9 are based primarily
FIG. 11 is a backscatter SEM micrograph of Dy20 3—
upon SEM investigations performed on dysprosium lithium
Li20 —B20 3 microspheres which have reacted in the rat to
borate (Dy20 3—L i02—B20 3) glass microspheres which
form dysprosium phosphate and borosilicate glass particles
were reacted in phosphate buffered saline (PBS) solution.
(irregular shape) after two weeks in a rat knee. The rat knee
did not receive an EDTA injection so the insoluble dyspro 45 FIG. 7 shows the first microstructure characterized by a rigid
dysprosium phosphate shell filled with colloidal particles of
sium phosphate microspheres are still present along with the
the same composition obtained by reacting a glass compo
insoluble borosilicate particles; and
sition containing 3 wt. % Dy20 3 with PBS solution at 37° C.
FIG. 12 is a backscatter SEM micrograph of irregular
FIG. 8 shows the second type of microstructure previ
borosilicate glass particles remaining in a rat knee after the
ously
discussed above which can be described as a concen
addition of EDTA. Note that all microspheres have been 50
tric shell microstructure formed by reacting an “as-made”
completely dissolved by the EDTA and none are visually
dysprosium lithium borate glass containing 10 wt. % Dy20 3
detectable.
with PBS solution at 37° C.
DESCRIPTION OF THE PREFERRED
FIG. 9 shows the third type of microstructure formed by
EMBODIMENTS
55 the glass/aqueous solution reaction depicted in FIG. 3 and
can be described as a porous, homogenous gel formed by
In accordance with the present invention, it has now been
reacting an “as-made” dysprosium lithium borate glass
found that hollow/porous shells may be produced from glass
containing 30 wt. % Dy20 3 with PBS solution at 37° C.
particles by a method which can be carried out at or near
Because the glass contained such a high amount of insoluble
room temperature. The novel method of the invention
employs alkali borate glasses of an appropriate composition 60 dysprosium, a continuous gel formed during the glass/
aqueous solution reaction.
which are first crushed into particles or made into spheres of
the desired size. Pure alkali borate glasses have very poor
In the practice of the invention, the alkali borate glass
chemical durability and will completely dissolve when
employed may contain lithium, sodium, potassium,
immersed in aqueous solutions as shown in FIG. 1. In
rubidium or cesium individually or a mixture of these
accordance with the invention, the alkali borate glass com 65 alkalis. The cation contained in the alkali borate glass
positions utilized contain a cation such as a rare earth
composition may be an alkaline earth metal cation such as
(Dy3+), calcium or iron (Ca2+or Fe3+) which react with an
calcium, magnesium, strontium or barium, a transition metal
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cation such as chromium or zirconium (i.e. Cr3+ and Zr4+),
filled with colloidal particles or gel (FIG. 7), concentric
rare earth metal cation such as dysprosium, samarium,
shells (FIG. 8) or a porous, homogeneous gel (FIG. 9), these
yttrium or holmium (i.e. Dy3+, Sm3+, Y3+ and Ho3+) or an
microstructures being obtained by varying the amount of
aluminum (Al3+) or iron (Fe3+) cation. The anion or ligand
insoluble cation in the “as-made” glass composition utilized
contained in the aqueous solution reacted with the glass 5 for the glass/aqueous solution reaction. The products of the
composition may be hydroxide, oxygen, phosphate, sulfate,
method of the invention may be in the form of microspheres,
chromate, carbonate or other anion and hydrated forms
irregularly shaped particles or an assemblage of micro
thereof which will react with the cation in the glass com
spheres or irregularly shaped particles and may be filled with
position to form an aqueous insoluble material having a
a liquid, gas or solid material. Particles ranging in size from
solubility limit of less than about 0.01 wt. %. The insoluble
10 about 5 microns to larger than 1,000 microns can be con
material may be an oxide, hydroxide, phosphate, sulfate,
verted into porous gels. In addition, the product produced
chromate, carbonate or hydrated form thereof. For example,
through the practice of the invention may be further heat
when the aqueous solution is a body fluid containing phos
treated at an elevated temperature to modify the properties
phate anions, the insoluble material formed by chemical
(e.g. strength, porosity, permeability of the shell/gel).
reaction of these anions with cations such as calcium or
The products of the method of the invention may be found
15
aluminum would be calcium or aluminum phosphate.
useful in many different applications. Thus, the resulting
In the three microstructures of the products produced
heat treated product may be used as a filler in resins,
through the method of the present invention, the micro
polymers or metals to reduce weight and enhance strength or
graphs of FIGS. 7-9 are low magnification and do not show
in paints to vary the rheology of the paint. Biodegradable,
the existence of nanometer-size porosity which the dyspro
sium phosphate insoluble material in each microstructure 20 hollow/porous shells produced through the invention may be
impregnated with chemotherapeutic drugs, such as
possesses. Such porosity is advantageous in the use of such
methotrexate, doxorubicin, alpha, beta and gamma
materials as filtration or drug delivery devices where poros
interferons, alpha and beta tumor necrosis factors, antibiot
ity is essential.
ics or other known chemotherapeutic agents, and injected
The method of the present invention through the achieve
ment of non-uniform reaction of alkali borate glass compo 25 into malignant tissue to slowly deliver long term doses of
medication. Porous/hollow shells produced by the novel
sitions provides a number of advantages. An important and
practical advantage is that the method may be performed at
method of the invention and composed of refractory oxides,
low temperatures (i.e. room temperature or <100° C.). While
such as aluminum oxide (A120 3), could be sintered to form
the microspheres employed for aqueous reaction are pro
high purity, high temperature insulation. Porous/hollow
duced using a high temperature flame, the method of the 30 shells containing calcium and phosphorous could be used in
invention for preparing the porous/hollow shells is per
vivo to accelerate the growth of bone within the body or to
formed at or near room temperature. Room temperature
function as bone repair agents. Other uses for the products
processing allows porous/hollow shells to be produced and
of the invention include use as catalyst supports where
then filled with substances which will not tolerate high
refractoriness and high porosity would be beneficial and as
temperatures. These microspheres or glass compositions can 35 laser fusion targets, the porous/hollow shells being filled
be reacted as described and then filled with drug solutions or
with deuterium and tritium and used as targets for laser
organic materials useful for treating ailments and diseases
fusion. Still further, the porous shells/gels produced by the
within the body. Thus, low temperature processing of
method of the invention may be used as filters, precursors
porous/hollow shells constitutes a major advantage over the
for nano sized powders, as thin surface films or to remove
currently available high temperature methods described 40 hazardous species such as chromates, arsenates, uranates
above when the glass compositions are intended to be filled
and the like from solution. Another application for the
with substances that cannot withstand temperatures above
products of the method of the invention is for catalyst
about 100° C.
support media, i.e. the porous shells can be impregnated
Another advantage of the method of the invention is that
internally or coated on their surface with catalytic materials.
it can be used to produce hollow microspheres which are 45 Thus, the porous, hollow shells may be impregnated
also porous and hence easily tillable with various types of
throughout their thickness with metals such as platinum,
liquids, solids and gases. Microspheres produced by the
palladium or the like having catalytic properties. In each
burn-out and sol gel techniques previously described do not
instance, the product of the invention is nonradio active and
have porous walls and are difficult to fill with any substance.
not adapted for neutron irradiation.
Still another major advantage of the novel method of the 50
In another aspect of the invention, a method is provided
invention is that many different chemical compositions of
for administering a chemotherapeutic drug to a mammal
hollow microspheres can readily be produced. The compo
which involves the steps described above for forming a
sition of the porous/hollow shells is determined by whatever
primary product of the invention, followed by the steps of
insoluble cations are incorporated into the “as-made” glass
adding a chemotherapeutic drug to the product, administer
and by the anions in the solution. As mentioned above, such 55 ing the resulting product to a mammal and thereafter dis
cations may be rare earth metal cations, alkaline earth metal
solving the insoluble material from the product in vivo
cations, transition metal cations (like iron), aluminum or
through the administration of a chelating agent. As previ
actinide cations incorporated into alkali borate glasses to
ously noted, the primary product of the method of the
produce hollow/porous microspheres. Thus, the method of
invention is a porous material which is insoluble in solutions
the invention provides a major advantage over the high 60 with a near-neutral pFl such as most body fluids. Such a
temperature burn-out and sol gel methods since the latter
porous product is ideally suited for use in drug delivery since
only allow hollow microspheres to be formed from glass
the high concentration of nano-sized porosity allows the
forming constituents. With these two methods shells are
microspheres or gels to carry a relatively large amount of a
only oxides, but with the present invention shells can be a
drug to a treatment area within the body for slow release of
phosphate, hydroxide, sulfate, chromate, etc. compound.
65 the drug. For example, porous calcium phosphate micro
spheres made in accordance with the method of the inven
The three known microstructures which can be produced
tion as previously described are highly suitable for drug
by the method of the present invention are shown as a shell
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delivery because they are chemically similar to hard tissue
in the body and biocompatible. Such porous microspheres
can be produced by reacting alkali-calcium-borate glass
Inorganic Electrolyte
Concentration mM
microspheres with phosphate buffered saline (PBS) solution
and the resulting porous microspheres may be filled with a 5
Na+
153.1
K+
4.2
drug, such as an antibacterial agent, and injected into the
139.6
cr
body to treat an infected area. While such porous micro
PO<f3
9.6
spheres are thus highly suitable for drug delivery in this
manner, a potential complication lies in the removal of these
microspheres from the body after drug delivery therefrom 10 However, each of the glass compositions with 10 wt. % of
the metal oxides Dy20 3, Sm20 3 , Y20 3, Ho20 3, A120 3, Fe2
has been completed.
0 3 and CaO incorporated into a lithium borate glass as
In accordance with another aspect of the present
described above reacted non-uniformly when immersed in
invention, it has been found that hollow/porous micro
PBS solution at 37° C. FIG. 2 shows real time video
spheres may be removed from a living organism after drug
15 microscopy (RTVM) optical micrographs of three Dy20 3—
delivery therefrom has been accomplished through the
Li20 3—B20 3 glass microspheres chemically reacting nonadministration of a chelating agent. For this purpose, various
uniformly in PBS solution at times ranging from 0 to 75
chelating agents known in the art may be employed
minutes. As shown, a spherical core of “as-made” glass is
including, but not limited to, ethylenediaminetetraacetic
clearly visible after 15 minutes. Rather than dissolving
acid (EDTA), diethylenetriaminepentaacetic acid (DTPA),
uniformly and becoming progressively smaller, a shell forms
nitrilotriacetic acid (NTA), trimethylenediaminetetraacetic 20 at the original surface of the glass microsphere and a core of
acid, trie thy lenetetraaminehexaace tic acid, 1, 4, 7, 10 tet“as made” glass continues to react until it has completely
raacetic acid and hydroxyethylethylenediaminetriacetic acid
reacted leaving a spherical corrosion product behind.
(HEDTA). It will be understood that other chelating agents
A reaction rate was calculated for each glass composition
known to the art may also be employed in the practice of this
prepared as described above by measuring the shrinkage in
method for dissolving or chelating the insoluble material 25 the core radius as a function of time from optical micro
from the microspheres after drug delivery has been
graphs obtained using RTVM. The non-uniform reaction
achieved.
rates calculated for each glass immersed in PBS solution at
37° C. are given in the following table and vary between 6
As shown by the experimental results set forth hereinafter
and by reference to FIGS. 10-12, the chelating agent eth 30 and 11 /rm/h:
ylenediaminetetraacetic acid (EDTA) was effective in dis
solving porous dysprosium and calcium phosphate micro
spheres produced by alkali borate glass/aqueous solution
Metal Oxide Incorporated
Reaction Rate
reaction in vitro and dissolving dysprosium phosphate in
Into the Li20 — B20 3 Glass*
(urn/h)**
vivo. Thus, in the in vitro chelation tests, calcium lithium 35
Dy20 3
6
borate or dysprosium lithium borate glass microspheres
Sm20 3
10
were placed in PBS solution at 37° C. and allowed to
y 2o 3
6
completely react to form calcium phosphate or dysprosium
H o20 3
11
phosphate microspheres. In the in vivo tests, the knees of
a i 2o 3
11
Fe20 3
10
several Sprague Dawley rats were injected with equal 40
CaO
7
weights of dysprosium lithium borate microspheres and a
borosilicate glass control. In both the in vitro and in vivo
*10 wt. % metal oxide added to a 11.25 wt. % Li20 , 78.75 wt. % B20 3
tests, the administration of ethylenediaminetetraacetic acid
glass
**Rate at which the core of “as-made” glass radially shrinks during nonwas effective in dissolving or removing the calcium or
uniform reaction.
dysprosium phosphate materials.
45
These reaction rates are high enough to completely react
The following examples illustrate the practice of the
15/rm microspheres in PBS solution at 37° C. within 2 hours.
invention.
The mechanisms which occur during non-uniform reac
tion are shown in FIG. 3. Non-uniform reaction is initiated
EXAMPLE 1
50 at the original surface of each glass microsphere, as lithium
and boron dissolve into the surrounding solution. The
Glass microspheres were prepared by first mixing 45 g of
insoluble cations in the glass (i.e. Dy3+) are not completely
a lithium borate glass frit (12.5 wt. % Li20 , 87.5 wt. %
dissolved into solution. Rather, these cations react with OHB20 3) with 5 g of the metal oxides Dy20 3, Sm20 3, Y20 3,
and/or P 0 43- anions present in the aqueous solution adjacent
H o20 3, A120 3, Fe20 3 and CaO, respectively. The mixed
55 to the reacting glass to form an insoluble, amorphous,
powders were then placed in a platinum crucible, melted at
gel-like shell at the surface of each glass microsphere. As
1100° C. for 15 minutes, and then cast onto a stainless steel
time elapses, continued alkali and boron dissolution can
plate. The quenched glass was crushed by mortar and pestle
cause the core of “as-made” glass to shrink, and separate
and introduced into a propane air flame to form micro
from the outer shell. If core separation occurs, another shell
spheres 5 to 15 fim in diameter. Visual inspection of the
60 will begin to form around the detached glass core as the
microspheres during aqueous corrosion was facilitated by
insoluble cations again react with ions in the aqueous
their spherical shape and small size.
solution. These core separation and shell formation steps
continue to occur until the core of “as-made” glass has
As shown in FIG. 1, pure lithium borate (Li20 —B20 3)
completely reacted.
glass microspheres chemically reacted in a uniform manner
and become progressively smaller when immersed in phos 65
This non-uniform reaction generally results in the forma
phate buffered saline solution (PBS) having the following
tion of porous/hollow shells which remain the same size and
composition at 37° C.:
shape as the “as-made” microspheres. The reacted micro
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spheres are generally composed of concentric shells of a
porous hydroxide or phosphate gel. If, for example, a
Dy20 3—Li20 —B20 3 glass microsphere is reacted in PBS
solution, the reacted microspheres will be composed of
concentric shells of an amorphous dysprosium phosphate
gel. If there is no phosphorous present in the solution (i.e.
saline solution), the reacted microspheres will be composed
of concentric shells of an amorphous dysprosium hydroxide
gel.

These microstructures are obtained by varying the amount of
insoluble cation in the “as-made” glass used for glass/
solution reaction. The microstructures may also be varied by
varying the amount of anion in the solution. FIGS. 7-9 show
5 three microstructures obtained by reacting the respective
glass with PBS solution, dehydrating the microspheres with
ethanol, monomer infiltrating with methyl methacrylate
monomer (MMA) and subsequently polymerizing (PMMA)
before viewing by backscatter SEM.
10
The first microstructure shown in FIG. 7 is characterized
EXAMPLE 2
by a rigid dysprosium phosphate shell filled with colloidal
particles of the same composition. This microstructure was
Large (100 to 200 fim in diameter) Dy20 3—Li20 —B20 3
obtained by reacting a glass containing 3 wt. % Dy20 3 with
microspheres were reacted in PBS solution at 37° C. to
PBS solution at 37° C. FIG. 7 shows a cross sectional view
investigate the internal microstructure of microspheres
which were non-uniformly reacted. The large Dy20 3— 15 of a reacted dysprosium-lithium borate microsphere which
initially contained 3 wt. % Dy20 3. There is a 95% weight
Li20 —B20 3 glass microspheres were immersed in PBS
loss associated with the formation of this shell-type micro
solution for 24 hours at 37° C., dehydrated with ethanol and
structure.
then impregnated with poly-methyl methacrylate. These
polymer-impregnated microspheres were then crossThe second type of microstructure is shown in FIG. 8 and
sectioned with a diamond saw, polished and examined by 20 can be described as a concentric shell microstructure. This
SEM. FIG. 4 shows the cross section of a Dy20 3—Li20 —
microstructure was formed by reacting an “as-made”
B20 3 microsphere after non-uniform reaction in PBS solu
dysprosium-lithium borate glass which contained 10 wt. %
tion. The concentric shells of dysprosium phosphate are
Dy20 3 with PBS solution. An 80% weight loss is associated
easily seen in FIG. 4. Although a concentric shell micro
with the formation of this microstructure from the “as25
structure is generally produced using this technique, com
made” glass.
pletely hollow microspheres may be produced by decreasing
The third microstructure formed by glass/solution reac
the wt. % of the insoluble metal oxide in the “as-made”
tion is shown in FIG. 9 and can be described as a porous,
microspheres, or by reacting the “as-made” microspheres in
homogeneous gel. The “as-made” dysprosium-lithium
acidic or basic solutions.
borate glass used to make this microstructure initially con
30
Eligh resolution SEM was used to analyze the pore
tained 30 wt. % Dy20 3. A continuous porous, homogeneous
structure of the large reacted microspheres. FIGS. 5 and 6
gel formed during glass/solution reaction because the glass
show high magnification SEM micrographs of “as-made”
contained such a high amount of insoluble dysprosium. A
and reacted (PBS) Dy20 3—Li20 —B20 3 glass surfaces,
60% weight loss is associated with the formation of this
respectively. The “as-made” surface is smooth and dense,
microstructure
from the “as-made” glass. While the micro
35
while the reacted surface is porous and rough with pore radii
structure shown in FIG. 9 appears as though it is composed
approximately 35 nm in diameter. These high resolution
of a solid microsphere, it is actually porous on the 30 to 50
SEM micrographs establish that the concentric shells formed
nm level which is advantageous in the use of these micro
during non-uniform reaction are porous.
structure materials as filtration or drug delivery devices
where
porosity would be essential.
40
EXAMPLE 3
EXAMPLE 6
Microspheres 5 to 15 fim in diameter were placed in
polycarbonate filter packets and allowed to react in PBS
solution at 37° C. for time intervals ranging from 0.25 to 64
days. After each time interval, the packets were removed
from the PBS solution and the weight loss was determined.
Only Dy20 3—Li20 —B20 3 glasses were analyzed using
this weight loss technique, and these glasses lost 75% of
their original weight in less than six hours. After reacting 6
hours in PBS solution, no further weight loss occurred.
Thus, reaction in aqueous solutions can be used to convert
the solid glass microspheres into highly porous shells in
short periods of time.
EXAMPLE 4
Nitrogen absorption surface area analysis was performed
on “as-made” microspheres and microspheres which were
immersed in PBS solution for 24 hours at 37° C. and then air
dried. The specific surface area (SSA) of Dy20 3—Li20 —
B20 3 microspheres increased by over 1000 times after being
immersed in PBS solution at 37° C. for 24 hours. This huge
increase in SSA provides further proof that the concentric
shells formed during non-uniform reaction are porous.
EXAMPLE 5
Three known microstructures can be produced by the
glass/solution reaction method of the present invention.

45

50

55

60

65

The following i vitro and in vivo chelation experiments
were performed to determine whether the porous micro
spheres formed by glass/solution reaction could be dissolved
with a chelating agent such as ethylenediaminetetraacetic
acid (EDTA).
The in vitro EDTA chelation tests were performed by
placing either calcium-lithium borate or dysprosium-lithium
borate glass microspheres in PBS solution at 37° C. and
allowing them to completely react to form a calcium phos
phate or dysprosium phosphate. After porous calcium phos
phate or dysprosium phosphate microspheres were formed,
a small amount (25 fil of 0.75M EDTA solution) was added
to dissolve the particles.
The EDTA chelation was effective in completely dissolv
ing the hollow calcium and dysprosium phosphate materials
in vitro. FIG. 10 shows micrographs from an in vitro EDTA
chelation test performed on dysprosium-lithium borate glass
microspheres. The top three micrographs show the
dysprosium-lithium borate glass microspheres reacting with
the PBS solution to form shells of a porous dysprosium
phosphate. Note the appearance of a reaction layer in
micrograph 10B which moves inward (10C) until the entire
sphere has reacted (10D). The irregularly shaped particles in
each micrograph of FIG. 10 are borosilicate glass particles
(Pyrex™) which are used as inert markers since they are not
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dissolved by EDTA. These particles were added to act as a
comparative control material. EDTA was added prior to the
fourth micrograph (10D) (1 hr., 42 minutes into the test), and
the microspheres were completely dissolved within 25 min
utes (FIG. 10F). Thus, FIGS. 10D-10F show the disappear 5
ance of the dysprosium phosphate shells after the EDTA was
added at 1 hr., 42 minutes, but the irregularly-shaped borosilicate glass particles which do not react with EDTA remain
unaffected after the addition of EDTA.
Similar results were obtained with calcium-lithium borate 10
microspheres thus demonstrating that EDTA is effective in
dissolving the porous materials produced by glass/solution
reaction in vitro.
For an in vivo experiment, the knees of several Sprague
Dawley rats were injected with approximately 1.0 mg of an 15
equivolumetric ratio of “as-made” dysprosium-lithium
borate microspheres and irregularly-shaped borosilicate
glass particles. The borosilicate particles were used as a
control, since they are unaffected by EDTA. One day after
injection, half of the knees were injected with 25 fil of 0.75M 20
EDTA solution, while the other half were not injected with
EDTA. All rats were then sacrificed approximately two
weeks after receiving the initial injection of microspheres
and borosilicate particles.. All knees were excised,
dehydrated, monomer infiltrated with methyl methacrylate 25
monomer (MMA) and polymerized (PMMA).
The polymerized knees were sectioned and examined by
SEM to determine whether EDTA was effective in removing
the microspheres from the knees. FIG. 11 is a micrograph
30
showing the knee of a rat which was injected with a mixture
of “as-made” glass microspheres and borosilicate glass
particles without receiving an EDTA injection. During the
two week period the “as-made” micropheres were in the rat,
they reacted with the body fluids to form insoluble dyspro
35
sium phosphate. Since the knee was not injected with EDTA,
the insoluble reacted microspheres are still present along
with the insoluble borosilicate glass particles. In contrast,
FIG. 12 is a SEM micrograph showing the knee of a rat that
was also injected with the same mixture of “as-made” glass
40
microspheres and borosilicate glass particles that was used
for the rat in FIG. 11, but was also injected with EDTA. As
shown, all of the reacted microspheres were dissolved from
the knee by the EDTA in FIG. 12 and only the irregularlyshaped borosilicate glass particles remain. This in vivo test
45
thus confirmed the results of the in vitro test showing that the
EDTA chelating agent is effective in dissolving the porous
microspheres produced by glass/solution reaction within the
body.
In view of the above, it will be seen that the several 50
objects of the invention are achieved and other advantageous
results attained.
As various changes could be made in the above methods
without departing from the scope of the invention, it is
intended that all matter contained in the above description or 55
shown in the accompanying drawings shall be interpreted as
illustrative and not in a limiting sense.
What is claimed is:
1.
A method for preparing a shell or porous gel from glass
particles which comprises the steps of:
60
(a) forming particles of an alkali borate glass composition
containing one or more cations which react with an
aqueous solution containing an anion reactive with said
cation to form an aqueous insoluble material having a
solubility limit of less than about 0.01 wt. %;
65
(b) immersing said glass composition particles in said
aqueous solution to cause reaction of said particles to
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form said insoluble material which is essentially the
same size as the as-made particles with the alkali and
boron dissolving from the glass particles; and
(c) allowing said reaction to continue until said alkali and
boron are substantially completely dissolved from said
glass particles and the resulting product is composed of
a shell filled with colloidal particles or gel, concentric
shells or a porous, homogenous gel, said product being
nonradioactive and not adapted for neutron irradiation.
2. A method as set forth in claim 1 wherein said alkali is
lithium.
3. A method as set forth in claim 1 wherein said alkali is
sodium.
4. A method as set forth in claim 1 wherein said alkali is
potassium.
5. A method as set forth in claim 1 wherein said alkali is
rubidium.
6. A method as set forth in claim 1 wherein said alkali is
cesium.
7. A method as set forth in claim 1 wherein said alkali is
constituted by a mixture of alkalis.
8. A method as set forth in claim 1 wherein said insoluble
material is selected from the group consisting of oxides,
hydroxides, phosphates, sulfates, chromates, carbonates and
hydrated forms thereof.
9. A method as set forth in claim 8 wherein said insoluble
material is an oxide.
10. Amethod as set forth in claim 8 wherein said insoluble
material is a phosphate.
11. A method as set forth in claim 1 wherein said cation
is selected from the group consisting of alkaline earth metal
cations, transition metal cations, rare earth cations, alumi
num and actinides.
12. Amethod as set forth in claim 11 wherein said alkaline
earth metal cation is selected from the group consisting of
magnesium, calcium, strontium and barium.
13. A method as set forth in claim 11 wherein said cation
is aluminum.
14. A method as set forth in claim 11 wherein said cation
is iron.
15. Amethod as set forth in claim 1 wherein said anion or
ligand is selected from the group consisting of hydroxide,
oxygen, phosphate, sulfate, chromate, carbonate and
hydrated forms thereof.
16. A method as set forth in claim 15 wherein said anion
is hydroxide.
17. A method as set forth in claim 15 wherein said anion
is oxygen.
18. A method as set forth in claim 15 wherein said anion
is phosphate.
19. A method as set forth in claim 1 wherein said product
is in the form of microspheres, irregularly shaped particles
or an assemblage of microspheres or irregularly shaped
particles.
20. A method as set forth in claim 1 wherein said steps are
carried out at a temperature below approximately 100° C.
21. A method as set forth in claim 20 wherein said
temperature is room temperature or a temperature of 37V C.
22. A method as set forth in claim 1 wherein said product
produced in step (c) is filled with a liquid, gas or solid
material.
23. A method as set forth in claim 22 wherein said filler
material is a chemotherapeutic drug.
24. A method as set forth in claim 1 wherein said product
produced in step (c) is dried and heat treated at an elevated
temperature.
25. Amethod as set forth in claim 24 wherein the resulting
heat treated product is added to paints, resins, polymers or
metals.
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26. A method as set forth in claim 24 wherein the resulting
(e) thereafter dissolving said insoluble material from said
heat treated product is administered to a mammal as a bone
resulting product in vivo through the administration of
growth or repair agent.
a chelating agent.
27. A method as set forth in claim 24 wherein said
30. A method as set forth in claim 29 wherein said
resulting heat treated product is added to a solution to 5
chelating agent is ethylenediaminetetracetic acid.
remove therefrom a hazardous species selected from the
31. A method as set forth in claim 29 wherein said alkali
group consisting of chromates, arsenates and uranates.
is lithium.
28. A method as set forth in claim 24 wherein said
32. A method as set forth in claim 29 wherein said alkali
resulting heat treated product is impregnated internally or
coated on its surface with catalytic material.
10 is sodium.
29. A method for administering a chemotherapeutic drug
33. A method as set forth in claim 29 wherein said alkali
which comprises the steps of
is potassium.
(a) forming particles of an alkali borate glass composition
34. A method as set forth in claim 29 wherein said
containing a cation which reacts with an aqueous
insoluble material is selected from the group consisting of
solution containing an anion reactive with said cation to 15 oxides, hydroxides, phosphates, sulfates, chromates, carbon
form an aqueous insoluble material having a solubility
ates and hydrated forms thereof.
limit of less than about 0.01 wt. %;
35. A method as set forth in claim 34 wherein said
(b) immersing said glass composition particles in said
insoluble material is an oxide.
aqueous solution to cause a reaction of said particles to
36. A method as set forth in claim 34 wherein said
form said insoluble material which is essentially the 20
insoluble
material is a phosphate.
same size as the as-made particles with the alkali and
37. A method as set forth in claim 29 wherein said product
boron dissolving from the glass particles;
produced in step (c) is in the form of microspheres, irregu
(c) allowing said reaction to continue until said alkali and
boron are substantially completely dissolved from said 25 larly shaped particles or an assemblage of microspheres or
irregularly shaped particles.
glass particles and the resulting product is composed of
a shell filled with colloidal particles or gel, concentric
38. A method as set forth in claim 29 wherein said steps
shells or a porous, homogenous gel, said product being
(a), (b) and (c) are carried out at a temperature below
nonradioactive and not adapted for neutron irradiation;
approximately 100° C.
(d) adding a chemotherapeutic drug to said product and
administering the resulting product to a mammal; and
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